Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Transcode Therapeutics, Inc. | Director | Stock Option (right to buy) | 70K | Jun 14, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
RNAZ | Transcode Therapeutics, Inc. | Jun 14, 2024 | 1 | $0 | 4 | Jun 18, 2024 | Director |
RNAZ | Transcode Therapeutics, Inc. | May 19, 2023 | 1 | $0 | 4 | May 19, 2023 | Director |
RNAZ | Transcode Therapeutics, Inc. | May 10, 2023 | 1 | $0 | 4 | May 10, 2023 | Director |
RNAZ | Transcode Therapeutics, Inc. | Jun 22, 2022 | 1 | $0 | 4 | Jun 22, 2022 | Director |
RNAZ | Transcode Therapeutics, Inc. | Jul 8, 2021 | 0 | $0 | 3 | Jul 8, 2021 | Director |